| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season
|
Dos Santos, Gael
|
|
|
43 |
3 |
p. 265-279
|
artikel
|
| 2 |
Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study
|
Kolberg, Hans-Christian
|
|
|
43 |
3 |
p. 233-242
|
artikel
|
| 3 |
Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database
|
Berbain, Thomas
|
|
|
43 |
3 |
p. 243-253
|
artikel
|
| 4 |
Drug-Induced Hypophosphatemia: Current Insights
|
Megapanou, Efstathia
|
|
|
43 |
3 |
p. 197-210
|
artikel
|
| 5 |
Fatal Toxicity Indices for Medicine-Related Deaths in New Zealand, 2008–2013
|
Fountain, John S.
|
|
|
43 |
3 |
p. 223-232
|
artikel
|
| 6 |
Follow-Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under-Reporting in Oncology Trials?
|
Ménard, Timothé
|
|
|
43 |
3 |
p. 295-296
|
artikel
|
| 7 |
Insight into the Severity of Adverse Drug Reactions as Experienced by Patients
|
Rolfes, Leàn
|
|
|
43 |
3 |
p. 291-293
|
artikel
|
| 8 |
Prenatal Exposure to Macrolides and Risk of Congenital Malformations: A Meta-Analysis
|
Mallah, Narmeen
|
|
|
43 |
3 |
p. 211-221
|
artikel
|
| 9 |
Spontaneous Fluctuations in Liver Biochemistries in Patients with Compensated NASH Cirrhosis: Implications for Drug Hepatotoxicity Monitoring
|
Shamseddeen, Hani
|
|
|
43 |
3 |
p. 281-290
|
artikel
|
| 10 |
The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK
|
Klein, Kevin
|
|
|
43 |
3 |
p. 255-263
|
artikel
|
Tijdschrift beschrijving